Skip to main content
. 2024 Jan 4;69(3):1004–1014. doi: 10.1007/s10620-023-08226-3

Table 2.

Biochemical findings

Characteristics Baseline (earliest available data) At time of pseudocirrhosis diagnosisa Last valueb
Laboratory data, median (IQR)
 Alkaline phosphatase (U/L) 70 (44–124) 182 (135–286)* 263 (148.5–509)*
 Total protein (g/dL) 7.2 (6.6–7.5) 6.7 (6.0–7.5) 6.7 (5.3–7.2)*
 Albumin (g/dL) 4.2 (3.8–4.5) 3.5 (3.0–3.9)* 3.3 (2.8–3.6)*
 Total bilirubin (mg/dL) 0.4 (0.2–0.7) 0.5 (0.4–0.9)* 1 (0.5–3.0)
 ALT (U/L) 19 (15–28) 25 (19–45) 39 (19–102.5)*
 AST (U/L) 22 (19–29) 54 (36–98)* 68.5 (46–116)*
 INR 1.0 (0.9–1.0) 1.1 (1.0–1.2)* 1.3 (1.1–1.7)*
 R factor 0.82 (0.4–1.88) 0.42 (0.27–0.57)* 0.39 (0.22–0.87)*
 Platelet count 214 (188–252.5) 179 (122–265) 175 (89–266)

*p < 0.05 after Tukey’s adjustment for the comparison with the baseline value

aDays from baseline to pseudocirrhosis diagnosis, Median (IQR): 70 (14–259)

bDays from pseudocirrhosis diagnosis to last value, Median (IQR): 1108.5 (815–2012)